Home » Eli Lilly » Citigroup analyst Andrew Baum maintains Eli Lilly and Co with a Buy

Citigroup analyst Andrew Baum maintains Eli Lilly and Co with a Buy

By legume / April 3, 2024 / Eli Lilly

Citigroup analyst Andrew Baum maintains Eli Lilly and Co with a Buy and raises the price target from $675 to $895.

Intel Expects To Accelerate On Its Path Toward Achieving Ambition Of 60% Non-GAAP Gross Margins And 40% Non-GAAP Operating Margins In 2030

RBC Capital analyst Jonathan Atkin maintains Verizon Communications (NYSE:VZ) with a Sector Perform